Proactive Investors - Run By Investors For Investors

Supreme Pharma appoints La Brier chairman, Dhaliwal CFO

Supreme Pharmaceuticals says it has strengthened its board of directors, following receipt of the federal licence to cultivate marijuana at its seven-acre (342,000 square feet) hybrid greenhouse facility in Kincardine, Ontario
Supreme Pharma appoints La Brier chairman, Dhaliwal CFO
Board changes at Supreme

Supreme Pharmaceuticals Inc. (CNSX:SL) said on Monday it has strengthened its board of directors, following receipt of the federal licence to cultivate marijuana at its seven-acre (342,000 square feet) hybrid greenhouse facility in Kincardine, Ontario.

Michael La Brier joins the board of directors as chairman. Mr. La Brier is a successful Toronto-based real estate developer. La Brier will be joined on the board by Scott Walters.

Meanwhile, Navdeep Dhaliwal, CA, a current director of Supreme, has been appointed the chief financial officer.

La Brier brings a wealth of entrepreneurial and governance experience to Supreme from his prior positions as president of Canderel Stoneridge, a large real estate development firm, and trustee and chair of the governance committee at Primaris REIT. La Brier will be replacing Chris Bechtel, who has stepped down as both chairman and director.

La Brier stated: "As a long-standing shareholder, I am excited to join the board and assist the management team in meeting its short-term and long-term growth objectives. Management has done a great job laying the groundwork for Supreme to obtain a leadership position in the cannabis market. With the licence in hand, I believe the road ahead for Supreme is bright."

Walters is a former investment banker and hedge fund manager who has become a leading figure in the emerging marijuana industry.

Walters was the start-up chief executive officer of another Canadian company that is now a licensed producer and currently is CEO of a successful US-based medical support business focused on the needs of patients suffering from chronic and disabling illnesses utilizing cannabinoids to improve their quality of life.

Dhaliwal has an extensive background in capital markets and the growth of new ventures. He is a chartered accountant and began his career with KPMG LLP. Mr. Dhaliwal replaces former interim CFO Cailin Ghelsen, who will remain with the company's finance department.

Supreme also announced that it has granted 800,000 options to purchase common shares of the company to the new directors pursuant to the terms of the company's option plan. The options have an exercise price of 75 cents.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full SL profile View Profile

Supreme Pharmaceuticals Timeline

Related Articles

Scientist conducting work
Sun
CaPre, a potent form of Omega-3, has been shown to reduce triglycerides, but also lower 'bad cholesterol' levels, and raise 'good' ones
scientist at petrie dish
May 15 2019
Here we take a closer look at Midatech Pharma PLC (LON:MTPH)
cancerous cells
March 08 2019
A series of trials underway at major cancer research hospitals are evaluating the company's flagship cancer drug Ampligen
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use